Onmark Vision: Pioneering a new GPO community that’s built by and for retina specialists

Our goal is to become the largest aggregator of retina drug products in the U.S. for independent retina practices. Founded in 2024, Onmark® Vision, an exclusive group purchasing organization (GPO) program, has had an impressive start. In our first three quarters alone, the program has already reached over $1 billion in annual purchasing power. Join us in revolutionizing community retina by creating the best-in-class member organization.

Onmark Vision is advancing access to new therapies and superior clinical technology and support, not to mention access to the leading dedicated eye platform: RetinaOS.

Our mission is to be the leading physician-led GPO program for elite community retina and eye care professionals, uniting practices to maximize buying power to secure the best, differentiated contracts. This will fuel better practice health and patient care while fostering a collaborative community. Ready to learn more?

Ask how you can join this exclusive GPO. Contact us today to learn more.

Supercharge your buying power

As an Onmark Vision member, you can be part of a collective purchasing group to secure better pricing on crucial retina and eye disease products. This collaborative network’s goal is to deliver significant cost savings for your practice and help you get the best economics on essential retina drug products, ultimately enhancing your practice's financial health.

We work closely with our biopharma partners to negotiate better contract structures that maximize performance, aiming to provide you with the most advantageous terms and support for your needs:

Tailored contract opportunities for your practice
Focus on strategies and differentiated opportunities
Customized planning for practice economic longevity

Access the latest retina therapies

We understand the importance of staying ahead in a rapidly evolving industry. Our strong partnerships with biopharma enable us to offer the latest innovative therapies. Be confident you're providing the best care possible with cutting-edge therapies that can make a difference in your patients' lives.

Here are a few of the future spaces we’re targeting:

Wet age-related macular degeneration (Wet AMD)
Dry age-related macular degeneration (Dry AMD)
Diabetic macular edema (DME)
Diabetic retinopathy (DR)
Myopic choroidal neovascularization (mCNV)
Macular edema following retinal vein occlusion (RVO)

Tap into trusted advisors

Our team of impartial business and clinical advisors act as fierce advocates for your retina practice, supporting you in achieving your financial, operational, and clinical goals. Leading through collaboration, our customized approach complements your staff and helps guide your practice to a prosperous future.

Our comprehensive services include:

Optimizing overall profitability by factoring in both drug and non-drug costs, as well as reimbursement data
Providing reporting and actionable insights into market conditions and drug pipelines
Unlocking operational and financial potential with customized consulting services from our field-based pharmacists and business advisors
Driving clinical excellence with education, support with biosimilar and new therapies adoption, and training

Powering economic success for your practice

Our mission is to help you strategize for the future, while delivering the most cost savings now. The Onmark Vision team negotiates the best prices and contract performance opportunities for your retina practice and patients.

We’re unique in providing:

Custom strategy plans for the near- and long-term
Maximum earning potential across multiple contracts on the drugs you use
Proprietary analytic tools
Rebate earning potential calculator
Multi-scenario planning and focused opportunities
Advanced benchmarking

Other services we provide include:

ASP CMS reimbursement reviews at beginning- and end-of-quarter
Biweekly performance updates
Monthly strategy sessions and opportunity to review therapeutic interchange data
End-of-quarter strategy planning to understand maximum earning potential

Go beyond inventory with RetinaOS

Our cloud-based clinical workflow and inventory management system is built for the changing demands of today’s retina practices. RetinaOS provides better accountability, visibility, and analytics on the metrics that matter.

Improved overall inventory line-of-sight and drug reconciliation
Broader management of drug purchasing
Efficient clinical workflow of drug administration
Quicker reimbursement
Reduced risk of insufficient reimbursement

Be part of a collaborative community

Join a network of peers to collaborate and share ideas. You’ll have the opportunity to:

Shape the trajectory of Onmark Vision's contracts and maximize value for the group
Serve on a contract committee
Engage in monthly member calls
Attend the annual Onmark Vision Summit member event